Relationships between exercise, mitochondrial biogenesis and type 2 diabetes

Diabetes and Physical Activity

Volumn 60, Issue , 2014, Pages 48-61

  Joseph, Anna Maria ^a   Hood, David A ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL; GENETICS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; MOTOR ACTIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MITOCHONDRIA; MITOCHONDRIAL TURNOVER; MOTOR ACTIVITY; MUSCLE FIBERS, SKELETAL; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 84958117435     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000357335     Document Type: Chapter

References (137)

1. Patti ME, Corvera S: The role of mito- chondria in the pathogenesis of type 2 diabetes. Endocr Rev 2010;31:364-395.
2. Petersen KF, Shulman GI: Etiology of insulin resistance. Am J Med 2006; 119:S10-S16.
3. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH: Development of muscle insulin resis- tance after liver insulin resistance in high-fat-fed rats. Diabetes 1991;40: 1397-1403.
4. Russell JC, Shillabeer G, Bar-Tana J, Lau DC, Richardson M, Wenzel LM, Graham SE, Dolphin PJ: Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16. Diabetes 1998;47:770-778.
5. Hood DA: Mechanisms of exercise-in- duced mitochondrial biogenesis in skel- etal muscle. Appl Physiol Nutr Metab 2009;34:465-472.
6. Newsholme P, Gaudel C, Krause M: Mi- tochondria and diabetes. An intriguing pathogenetic role. Adv Exp Med Biol 2012;942:235-247.
7. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puig- server P, Carlsson E, Ridderstrale M, Laurila E, et al: PGC-1alpha-responsive genes involved in oxidative phosphory- lation are coordinately downregulated in human diabetes. Nat Genet 2003;34: 267-273.
8. Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, Shatzkes N, Neschen S, White MF, Bilz S, Sono S, et al: Reduced mito- chondrial density and increased IRS-1 serine phosphorylation in muscle of insu- lin-resistant offspring of type 2 diabetic parents. J Clin Invest 2005;115:3587-3593.
9. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Ko- hane I, Costello M, Saccone R, et al: Co- ordinated reduction of genes of oxida- tive metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003;100:8466-8471.
10. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE: Defi- ciency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005;54:8-14.
11. Hood DA: Invited review: contractile activity-induced mitochondrial biogen- esis in skeletal muscle. J Appl Physiol 2001;90:1137-1157.
12. Dillon LM, Rebelo AP, Moraes CT: The role of PGC-1 coactivators in aging skel- etal muscle and heart. IUBMB Life 2012; 64:231-241.
13. Scarpulla RC, Vega RB, Kelly DP: Tran- scriptional integration of mitochondrial biogenesis. Trends Endocrinol Metab 2012;23:459-466.
14. Larsson NG, Wang J, Wilhelmsson H, Oldfors A, Rustin P, Lewandoski M, Barsh GS, Clayton DA: Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 1998;18:231-236.
15. Wenz T, Rossi SG, Rotundo RL, Spiegel- man BM, Moraes CT: Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci USA 2009;106: 20405-20410.
16. Garnier A, Fortin D, Zoll J, N'Guessan B, Mettauer B, Lampert E, Veksler V, Ven- tura-Clapier R: Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J 2005;19:43-52.
17. Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, Gobelet C, Meier CA, Bell DR, Kralli A, Giacobino JP, De- riaz O: Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-acti- vated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Dia- betes 2003;52:2874-2881.
18. Short KR, Vittone JL, Bigelow ML, Proc- tor DN, Rizza RA, Coenen-Schimke JM, Nair KS: Impact of aerobic exercise training on age-related changes in insu- lin sensitivity and muscle oxidative ca- pacity. Diabetes 2003;52:1888-1896.
19. Anesti V, Scorrano L: The relationship between mitochondrial shape and func- tion and the cytoskeleton. Biochim Bio- phys Acta 2006;1757:692-699.
20. Chen H, Chan DC: Physiological func- tions of mitochondrial fusion. Ann N Y Acad Sci 2010;1201:21-25.
21. Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP, Leeuwenburgh C: New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci 2010;123:2533-2542.
22. Smirnova E, Griparic L, Shurland DL, van der Bliek AM: Dynamin-related protein Drp1 is required for mitochon- drial division in mammalian cells. Mol Biol Cell 2001;12:2245-2256.
23. Tieu Q, Nunnari J: Mdv1p is a WD re- peat protein that interacts with the dy- namin-related GTPase, Dnm1p, to trig- ger mitochondrial division. J Cell Biol 2000;151:353-366.
24. Yoon Y, Krueger EW, Oswald BJ, Mc- Niven MA: The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol 2003;23:5409-5420.
25. Romanello V, Sandri M: Mitochondrial biogenesis and fragmentation as regula- tors of muscle protein degradation. Curr Hypertens Rep 2010;12:433-439.
26. Twig G, Hyde B, Shirihai OS: Mitochon- drial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta 2008;1777: 1092-1097.
27. Pich S, Bach D, Briones P, Liesa M, Camps M, Testar X, Palacin M, Zorzano A: The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 2005; 14:1405-1415.
28. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, Smith CL, Youle RJ: The role of dyna- min-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001;1:515-525.
29. Chen H, Chomyn A, Chan DC: Disrup- tion of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 2005;280:26185-26192.
30. Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodri- guez M, Kellner U, Leo-Kottler B, Au- burger G, et al: OPA1, encoding a dyna- min-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 2000;26:211-215.
31. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Sen- derek J, et al: Mutations in the mito- chondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004;36:449-451.
32. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA: S-nitrosyl- ation of Drp1 mediates beta-amyloid- related mitochondrial fission and neuro- nal injury. Science 2009;324:102-105.
33. Waterham HR, Koster J, van Roermund CW, Mooyer PA, Wanders RJ, Leonard JV: A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 2007; 356:1736-1741.
34. Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A, Vogel H, Lu B: Pink1 regulates mitochondrial dynamics through interaction with the fission/ fusion machinery. Proc Natl Acad Sci USA 2008;105:7070-7075.
35. Cartoni R, Leger B, Hock MB, Praz M, Crettenand A, Pich S, Ziltener JL, Luthi F, Deriaz O, Zorzano A, et al: Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical ex- ercise. J Physiol 2005;567:349-358.
36. Ding H, Jiang N, Liu H, Liu X, Liu D, Zhao F, Wen L, Liu S, Ji LL, Zhang Y: Response of mitochondrial fusion and fission protein gene expression to exer- cise in rat skeletal muscle. Biochim Bio- phys Acta 2010;1800:250-256.
37. Soriano FX, Liesa M, Bach D, Chan DC, Palacin M, Zorzano A: Evidence for a mitochondrial regulatory pathway de- fined by peroxisome proliferator-acti- vated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. Diabetes 2006;55: 1783-1791.
38. Primeau AJ, Adhihetty PJ, Hood DA: Apoptosis in heart and skeletal muscle. Can J Appl Physiol 2002;27:349-395.
39. Petit PX, Goubern M, Diolez P, Susin SA, Zamzami N, Kroemer G: Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability tran- sition. FEBS Lett 1998;426:111-116.
40. Scarlett JL, Sheard PW, Hughes G, Led- gerwood EC, Ku HH, Murphy MP: Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 2000; 475:267-272.
41. Sandri M: Autophagy in skeletal muscle. FEBS Lett 2010;584:1411-1416.
42. Gomes LC, Scorrano L: High levels of Fis1, a pro-fission mitochondrial pro- tein, trigger autophagy. Biochim Bio- phys Acta 2008;1777:860-866.
43. Twig G, Elorza A, Molina AJ, Mo- hamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, et al: Fission and selective fusion govern mitochondrial segregation and elimi- nation by autophagy. EMBO J 2008;27: 433-446.
44. De Palma C, Morisi F, Cheli S, Pambi- anco S, Cappello V, Vezzoli M, Rovere- Querini P, Moggio M, Ripolone M, Francolini M, et al: Autophagy as a new therapeutic target in Duchenne muscu- lar dystrophy. Cell Death Dis 2012;3: e418.
45. O'Leary MF, Vainshtein A, Iqbal S, Os- tojic O, Hood DA: Adaptive plasticity of autophagic proteins to denervation in aging skeletal muscle. Am J Physiol Cell Physiol 2013;304:C422-C430.
46. Romanello V, Guadagnin E, Gomes L, Roder I, Sandri C, Petersen Y, Milan G, Masiero E, Del Piccolo P, Foretz M, et al: Mitochondrial fission and remodelling contributes to muscle atrophy. EMBO J 2010;29:1774-1785.
47. Wohlgemuth SE, Seo AY, Marzetti E, Lees HA, Leeuwenburgh C: Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp Gerontol 2010;45: 138-148.
48. Goodpaster BH, Theriault R, Watkins SC, Kelley DE: Intramuscular lipid con- tent is increased in obesity and de- creased by weight loss. Metabolism 2000;49:467-472.
49. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, Houmard JA: Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 2003; 284:E741-E747.
50. Kelley DE, Goodpaster B, Wing RR, Simoneau JA: Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999;277:E1130-E1141.
51. Ukropcova B, McNeil M, Sereda O, de Jonge L, Xie H, Bray GA, Smith SR: Dy- namic changes in fat oxidation in hu- man primary myocytes mirror metabol- ic characteristics of the donor. J Clin Invest 2005;115:1934-1941.
52. Gaster M, Rustan AC, Aas V, Beck- Nielsen H: Reduced lipid oxidation in skeletal muscle from type 2 diabetic sub- jects may be of genetic origin: evidence from cultured myotubes. Diabetes 2004; 53:542-548.
53. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004;350:664-671.
54. Guo LJ, Oshida Y, Fuku N, Takeyasu T, Fujita Y, Kurata M, Sato Y, Ito M, Tana- ka M: Mitochondrial genome polymor- phisms associated with type-2 diabetes or obesity. Mitochondrion 2005;5:15-33.
55. Juo SH, Lu MY, Bai RK, Liao YC, Trieu RB, Yu ML, Wong LJ: A common mito- chondrial polymorphism 10398A>G is associated metabolic syndrome in a Chinese population. Mitochondrion 2010;10:294-299.
56. van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PA, van de Kamp JJ, Maassen JA: Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedi- gree with maternally transmitted type II diabetes mellitus and deafness. Nat Gen- et 1992;1:368-371.
57. Asmann YW, Stump CS, Short KR, Coenen-Schimke JM, Guo Z, Bigelow ML, Nair KS: Skeletal muscle mitochon- drial functions, mitochondrial DNA copy numbers, and gene transcript pro- files in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 2006; 55:3309-3319.
58. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, Dela F: Pa- tients with type 2 diabetes have nor- mal mitochondrial function in skeletal muscle. Diabetologia 2007;50:790-796.
59. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, Klaus KA, Guo ZK, Sreekumar R, Irving BA: Asian Indians have enhanced skeletal muscle mitochondrial capacity to pro- duce ATP in association with severe insulin resistance. Diabetes 2008;57: 1166-1175.
60. Rabol R, Hojberg PM, Almdal T, Boushel R, Haugaard SB, Madsbad S, Dela F: Ef- fect of hyperglycemia on mitochondrial respiration in type 2 diabetes. J Clin En- docrinol Metab 2009;94:1372-1378.
61. Lowell BB, Shulman GI: Mitochondrial dysfunction and type 2 diabetes. Science 2005;307:384-387.
62. Petersen KF, Dufour S, Shulman GI: Decreased insulin-stimulated ATP syn- thesis and phosphate transport in mus- cle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med 2005;2: e233.
63. Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FG, Goodpaster BH, Ruderman NB, Kelley DE: Deficiency of electron transport chain in human skel- etal muscle mitochondria in type 2 dia- betes mellitus and obesity. Am J Physiol Endocrinol Metab 2010;298:E49-E58.
64. Bonnard C, Durand A, Peyrol S, Chan- seaume E, Chauvin MA, Morio B, Vidal H, Rieusset J: Mitochondrial dysfunc- tion results from oxidative stress in the skeletal muscle of diet-induced insulin- resistant mice. J Clin Invest 2008;118: 789-800.
65. Hancock CR, Han DH, Chen M, Terada S, Yasuda T, Wright DC, Holloszy JO: High-fat diets cause insulin resistance despite an increase in muscle mitochon- dria. Proc Natl Acad Sci USA 2008;105: 7815-7820.
66. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, Rolph MS, Cooney GJ: Excess lipid availability increases mitochondri- al fatty acid oxidative capacity in mus- cle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 2007;56:2085-2092.
67. Simoneau JA, Kelley DE: Altered glyco- lytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 1997;83:166-171.
68. Dyck DJ, Peters SJ, Glatz J, Gorski J, Keizer H, Kiens B, Liu S, Richter EA, Spriet LL, van der Vusse GJ, Bonen A: Functional differences in lipid metabo- lism in resting skeletal muscle of various fiber types. Am J Physiol 1997;272: E340-E351.
69. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, Yki-Jarvinen H, Christin L, Secomb TW, Bogardus C: Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987;80:415-424.
70. Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, Beck-Nielsen H, Hojlund K: Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007;56: 1592-1599.
71. Anderson EJ, Neufer PD: Type II skeletal myofibers possess unique properties that potentiate mitochondrial H2O2 gen- eration. Am J Physiol Cell Physiol 2006; 290:C844-C851.
72. Debard C, Laville M, Berbe V, Loizon E, Guillet C, Morio-Liondore B, Boirie Y, Vidal H: Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients. Diabetologia 2004;47: 917-925.
73. Heilbronn LK, Gan SK, Turner N, Campbell LV, Chisholm DJ: Markers of mitochondrial biogenesis and metabo- lism are lower in overweight and obese insulin-resistant subjects. J Clin Endo- crinol Metab 2007;92:1467-1473.
74. Sparks LM, Xie H, Koza RA, Mynatt R, Hulver MW, Bray GA, Smith SR: A high- fat diet coordinately downregulates genes required for mitochondrial oxida- tive phosphorylation in skeletal muscle. Diabetes 2005;54:1926-1933.
75. Wende AR, Schaeffer PJ, Parker GJ, Zechner C, Han DH, Chen MM, Hancock CR, Lehman JJ, Huss JM, McClain DA, et al: A role for the transcriptional coacti- vator PGC-1alpha in muscle refueling. J Biol Chem 2007;282:36642-36651.
76. Joseph AM, Pilegaard H, Litvintsev A, Leick L, Hood DA: Control of gene ex- pression and mitochondrial biogenesis in the muscular adaptation to endur- ance exercise. Essays Biochem 2006;42: 13-29.
77. Chen D, Guarente L: SIR2: a potential target for calorie restriction mimetics. Trends Mol Med 2007;13:64-71.
78. Chen D, Bruno J, Easlon E, Lin SJ, Cheng HL, Alt FW, Guarente L: Tissue-specific regulation of SIRT1 by calorie restric- tion. Genes Dev 2008;22:1753-1757.
79. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P: Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005;434:113-118.
80. Suwa M, Nakano H, Radak Z, Kumagai S: Endurance exercise increases the SIRT1 and peroxisome proliferator-acti- vated receptor gamma coactivator-1al- pha protein expressions in rat skeletal muscle. Metabolism 2008;57:986-998.
81. Bordone L, Cohen D, Robinson A, Motta MC, van Veen E, Czopik A, Steele AD, Crowe H, Marmor S, Luo J, et al: SIRT1 transgenic mice show phenotypes re- sembling calorie restriction. Aging Cell 2007;6:759-767.
82. Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH: Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci USA 2008; 105:9793-9798.
83. Frojdo S, Durand C, Molin L, Carey AL, El-Osta A, Kingwell BA, Febbraio MA, Solari F, Vidal H, Pirola L: Phos- phoinositide 3-kinase as a novel func- tional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol 2011;335:166-176.
84. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z, Puigserver P: Metabolic con- trol of muscle mitochondrial function and fatty acid oxidation through SIRT1/ PGC-1alpha. EMBO J 2007;26:1913-1923.
85. Jager S, Handschin C, St-Pierre J, Spie- gelman BM: AMP-activated protein ki- nase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1al- pha. Proc Natl Acad Sci USA 2007;104: 12017-12022.
86. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Mes- sadeq N, Milne J, Lambert P, Elliott P, et al: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC- 1alpha. Cell 2006;127:1109-1122.
87. Nemoto S, Fergusson MM, Finkel T: SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α. J Biol Chem 2005; 280:16456-16460.
88. Timmers S, Konings E, Bilet L, Hout- kooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, et al: Calorie restriction-like effects of 30 days of resveratrol supple- mentation on energy metabolism and metabolic profile in obese humans. Cell Metab 2011;14:612-622.
89. Menzies KJ, Singh K, Saleem A, Hood DA: Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogen- esis. J Biol Chem 2013;288:6968-6979.
90. Brehm A, Krssak M, Schmid AI, Nowot- ny P, Waldhausl W, Roden M: Increased lipid availability impairs insulin-stimu- lated ATP synthesis in human skeletal muscle. Diabetes 2006;55:136-140.
91. Chanseaume E, Malpuech-Brugere C, Patrac V, Bielicki G, Rousset P, Coutu- rier K, Salles J, Renou JP, Boirie Y, Mo- rio B: Diets high in sugar, fat, and en- ergy induce muscle type-specific adaptations in mitochondrial functions in rats. J Nutr 2006;136:2194-2200.
92. Toledo FG, Menshikova EV, Ritov VB, Azuma K, Radikova Z, DeLany J, Kelley DE: Effects of physical activity and weight loss on skeletal muscle mito- chondria and relationship with glucose control in type 2 diabetes. Diabetes 2007;56:2142-2147.
93. Abdul-Ghani MA, Muller FL, Liu Y, Chavez AO, Balas B, Zuo P, Chang Z, Tripathy D, Jani R, Molina-Carrion M, et al: Deleterious action of FA metabo- lites on ATP synthesis: possible link be- tween lipotoxicity, mitochondrial dys- function, and insulin resistance. Am J Physiol Endocrinol Metab 2008;295: E678-E685.
94. Kumashiro N, Tamura Y, Uchida T, Ogi- hara T, Fujitani Y, Hirose T, Mochizuki H, Kawamori R, Watada H: Impact of oxidative stress and peroxisome prolif- erator-activated receptor gamma coacti- vator-1alpha in hepatic insulin resis- tance. Diabetes 2008;57:2083-2091.
95. Bach D, Naon D, Pich S, Soriano FX, Vega N, Rieusset J, Laville M, Guillet C, Boirie Y, Wallberg-Henriksson H, et al: Expression of Mfn2, the Charcot-Marie- Tooth neuropathy type 2A gene, in hu- man skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 2005; 54:2685-2693.
96. Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J, Daugaard JR, Lloberas J, Camps M, Zierath JR, et al: Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mecha- nism altered in obesity. J Biol Chem 2003;278:17190-17197.
97. Kelley DE, He J, Menshikova EV, Ritov VB: Dysfunction of mitochondria in human skeletal muscle in type 2 diabe- tes. Diabetes 2002;51:2944-2950.
98. Joseph AM, Adhihetty PJ, Buford TW, Wohlgemuth SE, Lees HA, Nguyen LM, Aranda JM, Sandesara BD, Pahor M, Manini TM, et al: The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly indi- viduals. Aging Cell 2012;11:801-809.
99. Zhang Z, Wakabayashi N, Wakabayashi J, Tamura Y, Song WJ, Sereda S, Clerc P, Polster BM, Aja SM, Pletnikov MV, et al: The dynamin-related GTPase Opa1 is required for glucose-stimulated ATP production in pancreatic beta cells. Mol Biol Cell 2011;22:2235-2245.
100. Joseph AM, Joanisse DR, Baillot RG, Hood DA: Mitochondrial dysregula- tion in the pathogenesis of diabetes: potential for mitochondrial biogenesis- mediated interventions. Exp Diabetes Res 2012;2012:642038.
101. Masiero E, Agatea L, Mammucari C, Blaauw B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffino S, Sandri M: Autophagy is required to maintain muscle mass. Cell Metab 2009;10:507-515.
102. Yan J, Feng Z, Liu J, Shen W, Wang Y, Wertz K, Weber P, Long J, Liu J: En- hanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ame- liorating effects of (-)-epigallocate- chin-3-gallate. J Nutr Biochem 2012; 23:716-724.
103. Jung HS, Chung KW, Won Kim J, Kim J, Komatsu M, Tanaka K, Nguyen YH, Kang TM, Yoon KH, Kim JW, et al: Loss of autophagy diminishes pancre- atic beta cell mass and function with resultant hyperglycemia. Cell Metab 2008;8:318-324.
104. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW 3rd, Kang L, Rabinovitch PS, Szeto HH, et al: Mitochondrial H2O2 emis- sion and cellular redox state link ex- cess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009;119:573-581.
105. Evans JL, Maddux BA, Goldfine ID: The molecular basis for oxidative stress-induced insulin resistance. Anti- oxid Redox Signal 2005;7:1040-1052.
106. Maddux BA, See W, Lawrence JC Jr, Goldfine AL, Goldfine ID, Evans JL: Pro- tection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha- lipoic acid. Diabetes 2001;50:404-410.
107. Lambertucci RH, Hirabara SM, Silveira Ldos R, Levada-Pires AC, Curi R, Pithon-Curi TC: Palmitate increases superoxide production through mito- chondrial electron transport chain and NADPH oxidase activity in skeletal muscle cells. J Cell Physiol 2008;216: 796-804.
108. Nishikawa T, Edelstein D, Du XL, Ya- magishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, et al: Normalizing mito- chondrial superoxide production blocks three pathways of hyperglycae- mic damage. Nature 2000;404:787-790.
109. Haber CA, Lam TK, Yu Z, Gupta N, Goh T, Bogdanovic E, Giacca A, Fantus IG: N-acetylcysteine and taurine pre- vent hyperglycemia-induced insulin resistance in vivo: possible role of oxi- dative stress. Am J Physiol Endocrinol Metab 2003;285:E744-E753.
110. Szeto HH: Development of mitochon- dria-targeted aromatic-cationic pep- tides for neurodegenerative diseases. Ann N Y Acad Sci 2008;1147:112-121.
111. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, Szeto HH: Cell- permeable peptide antioxidants tar- geted to inner mitochondrial mem- brane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 2004;279:34682-34690.
112. Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, Beal MF: Cell-permeable peptide antioxidants as a novel thera- peutic approach in a mouse model of amyotrophic lateral sclerosis. J Neuro- chem 2006;98:1141-1148.
113. Szeto HH: Cell-permeable, mitochon- drial-targeted, peptide antioxidants. AAPS J 2006;8:E277-E283.
114. Thomas DA, Stauffer C, Zhao K, Yang H, Sharma VK, Szeto HH, Suthanthi- ran M: Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplanta- tion function. J Am Soc Nephrol 2007; 18:213-222.
115. Bravard A, Bonnard C, Durand A, Chauvin MA, Favier R, Vidal H, Rieus- set J: Inhibition of xanthine oxidase reduces hyperglycemia-induced oxida- tive stress and improves mitochondrial alterations in skeletal muscle of diabet- ic mice. Am J Physiol Endocrinol Metab 2011;300:E581-E591.
116. Holloszy JO: Biochemical adapta- tions in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 1967; 242:2278-2282.
117. Hoppeler H, Howald H, Conley K, Lind- stedt SL, Claassen H, Vock P, Weibel ER: Endurance training in humans: aerobic capacity and structure of skeletal mus- cle. J Appl Physiol 1985;59:320-327.
118. Richter EA, Garetto LP, Goodman MN, Ruderman NB: Muscle glucose metab- olism following exercise in the rat: in- creased sensitivity to insulin. J Clin Invest 1982;69:785-793.
119. Moro C, Pillard F, de Glisezinski I, Klimcakova E, Crampes F, Thalamas C, Harant I, Marques MA, Lafontan M, Berlan M: Exercise-induced lipid mo- bilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men. Am J Physiol Endocrinol Metab 2008;295: E505-E513.
120. Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ, Hawley JA: Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endo- crinol Metab 2003;88:5444-5451.
121. Goodpaster BH, He J, Watkins S, Kel- ley DE: Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001;86: 5755-5761.
122. Bruce CR, Kriketos AD, Cooney GJ, Hawley JA: Disassociation of muscle triglyceride content and insulin sensi- tivity after exercise training in patients with Type 2 diabetes. Diabetologia 2004;47:23-30.
123. Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN, Galbo H: Insulin-stimu- lated muscle glucose clearance in pa- tients with NIDDM. Effects of one- legged physical training. Diabetes 1995;44:1010-1020.
124. Schrauwen P, van Aggel-Leijssen DP, Hul G, Wagenmakers AJ, Vidal H, Sa- ris WH, van Baak MA: The effect of a 3-month low-intensity endurance training program on fat oxidation and acetyl-CoA carboxylase-2 expression. Diabetes 2002;51:2220-2226.
125. Meex RC, Schrauwen-Hinderling VB, Moonen-Kornips E, Schaart G, Men- sink M, Phielix E, van de Weijer T, Sels JP, Schrauwen P, Hesselink MK: Resto- ration of muscle mitochondrial func- tion and metabolic flexibility in type 2 diabetes by exercise training is paral- leled by increased myocellular fat stor- age and improved insulin sensitivity. Diabetes 2010;59:572-579.
126. Hey-Mogensen M, Hojlund K, Vind BF, Wang L, Dela F, Beck-Nielsen H, Fernstrom M, Sahlin K: Effect of physi- cal training on mitochondrial respira- tion and reactive oxygen species re- lease in skeletal muscle in patients with obesity and type 2 diabetes. Dia- betologia 2010;53:1976-1985.
127. He J, Goodpaster BH, Kelley DE: Ef- fects of weight loss and physical activ- ity on muscle lipid content and droplet size. Obes Res 2004;12:761-769.
128. Schrauwen-Hinderling VB, Schrauwen P, Hesselink MK, van Engelshoven JM, Nicolay K, Saris WH, Kessels AG, Kooi ME: The increase in intramyocellular lipid content is a very early response to training. J Clin Endocrinol Metab 2003;88:1610-1616.
129. De Filippis E, Alvarez G, Berria R, Cusi K, Everman S, Meyer C, Mandarino LJ: Insulin-resistant muscle is exercise resistant: evidence for reduced re- sponse of nuclear-encoded mitochon- drial genes to exercise. Am J Physiol Endocrinol Metab 2008;294:E607-E614.
130. Fritz T, Kramer DK, Karlsson HK, Ga- luska D, Engfeldt P, Zierath JR, Krook A: Low-intensity exercise increases skeletal muscle protein expression of PPARdelta and UCP3 in type 2 diabetic patients. Diabetes Metab Res Rev 2006; 22:492-498.
131. Musi N, Fujii N, Hirshman MF, Ekberg I, Froberg S, Ljungqvist O, Thorell A, Goodyear LJ: AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001;50:921-927.
132. Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P: Im- proved skeletal muscle oxidative en- zyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene ex- pression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int J Obes (Lond) 2007;31: 1302-1310.
133. Hernandez-Alvarez MI, Thabit H, Burns N, Shah S, Brema I, Hatunic M, Finucane F, Liesa M, Chiellini C, Naon D, et al: Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1α/Mito- fusin-2 regulatory pathway in response to physical activity. Diabetes Care 2010;33:645-651.
134. Ljubicic V, Adhihetty PJ, Hood DA: Application of animal models: chronic electrical stimulation-induced contrac- tile activity. Can J Appl Physiol 2005; 30:625-643.
135. Sriwijitkamol A, Coletta DK, Wajcberg E, Balbontin GB, Reyna SM, Barrientes J, Eagan PA, Jenkinson CP, Cersosimo E, DeFronzo RA, et al: Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study. Diabetes 2007;56:836-848.
136. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F: Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 diabetes. Diabetes 2004;53:294-305.
137. Menshikova EV, Ritov VB, Ferrell RE, Azuma K, Goodpaster BH, Kelley DE: Characteristics of skeletal muscle mi- tochondrial biogenesis induced by moderate-intensity exercise and weight loss in obesity. J Appl Physiol 2007;103:21-27.